Articles

< Previous         Next >  
Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses Free
Javier Mora1,2, Andrea Schlemmer1, Ilka Wittig3,4, Florian Richter3, Mateusz Putyrski5,6, Ann-Christin Frank1, Yingying Han1,7, Michaela Jung1, Andreas Ernst5,6, Andreas Weigert1,*, and Bernhard Brüne1,*
1Institute of Biochemistry I/ZAFES, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany
2Faculty of Microbiology, University of Costa Rica, 2060 San José, Costa Rica
3Functional Proteomics, SFB 815 Core Unit, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany
4Cluster of Excellence ‘Macromolecular Complexes’, Goethe University Frankfurt, 60590 Frankfurt, Germany
5Institute of Biochemistry II, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany
6Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine & Pharmacology TMP, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
7Faculty of Veterinary Medicine, Jilin University, 130062 Changchun, China *Correspondence to:Bernhard Brüne, E-mail: b.bruene@biochem.uni-frankfurt.de; Andreas Weigert, E-mail: weigert@biochem.uni-frankfurt.de
J Mol Cell Biol, Volume 8, Issue 5, October 2016, 426-438,  https://doi.org/10.1093/jmcb/mjw006
Keyword: apoptosis, IL-1 family, inflammation, cancer

Different modes of cell death regulate immunity. Whereas necrotic (necroptotic, pyroptotic) cell death triggers inflammation, apoptosis contributes to its resolution. Interleukin-1 (IL-1) family cytokines are key players in this interaction. A number of IL-1 family cytokines are produced by necrotic cells to induce sterile inflammation. However, release of IL-1 family proteins from apoptotic cells to regulate inflammation was not described. Here we show that IL-38, a poorly characterized IL-1 family cytokine, is produced selectively by human apoptotic cells to limit inflammation. Depletion of IL-38 in apoptotic cells provoked enhanced IL-6 and IL-8 levels and AP1 activation in co-cultured human primary macrophages, subsequently inducing Th17 cell expansion at the expense of IL-10-producing T cells. IL-38 was N-terminally processed in apoptotic cells to generate a mature cytokine with distinct properties. Both full-length and truncated IL-38 bound to X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL1). However, whereas the IL-38 precursor induced an increase in IL-6 production by human macrophages, truncated IL-38 reduced IL-6 production by attenuating the JNK/AP1 pathway downstream of IL1RAPL1. In conclusion, we identified a mechanism of apoptotic cell-dependent immune regulation requiring IL-38 processing and secretion, which might be relevant in resolution of inflammation, autoimmunity, and cancer.